Status:
ACTIVE_NOT_RECRUITING
Heart Health After Cancer Treatment (HEART-ACT)
Lead Sponsor:
University of California, San Francisco
Conditions:
Breast Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a pilot study testing multi-disciplinary health behavior intervention in breast cancer survivors who have been treated at Zuckerberg San Francisco General (ZSFG).
Detailed Description
OBJECTIVES: 1. Evaluating feasibility and acceptability of the program. 2. Evaluating the effects of the program on health outcomes including change in exercise capacity, change in quality of life, c...
Eligibility Criteria
Inclusion
- Age 18+
- Diagnosis of breast cancer
- Treated with curative intent
- Able to communicate in English, Spanish, or Cantonese
- Able to consent for self
- Receive care at Zuckerberg San Francisco General Hospital
Exclusion
- Chemotherapy, radiation, or surgery planned in next 3 months
- Life expectancy \< 1 year
Key Trial Info
Start Date :
November 7 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06055803
Start Date
November 7 2023
End Date
June 30 2026
Last Update
May 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zuckerberg San Francisco General
San Francisco, California, United States, 94115